Indeed, CUV's plan, although we sometimes bemoan and complain, does seem to be coming together very nicely in terms of revenue and profit. I REALLY want to buy more with the potential for the latest indications, but until I hear what the EMA say about the sixth indication, I'm actually afraid that, should it be negative, the historical shorting and manipulation could easily bring the SP to below $20 again. Having said that, with the historical safety data that CUV have produced upon which Scenesse has been approved as you say, I can't really see that they would spend time, effort and money on the sixth indication if they didn't believe that it would actually be efficacious to some degree.
In anticipation of a fruitful meeting with the EMA..........
GLA
- Forums
- ASX - By Stock
- Revenue EXPLOSION Coming?
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
0.85%
!
$10.49

Indeed, CUV's plan, although we sometimes bemoan and complain,...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.49 |
Change
-0.090(0.85%) |
Mkt cap ! $525.7M |
Open | High | Low | Value | Volume |
$10.58 | $10.68 | $10.41 | $803.9K | 76.15K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4258 | $10.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.68 | 4000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4258 | 10.450 |
1 | 214 | 10.420 |
3 | 4747 | 10.400 |
1 | 885 | 10.350 |
1 | 1000 | 10.320 |
Price($) | Vol. | No. |
---|---|---|
10.680 | 4000 | 3 |
10.690 | 4677 | 1 |
10.700 | 1258 | 1 |
10.750 | 100 | 1 |
10.780 | 500 | 1 |
Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |